- Nordic Nanovector Awarded NOK 12 Million in Funding From the Norwegian Research Council to Advance Alpha37, a Targeted Alpha Therapy for B-cell Cancers
- Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
- Nordic Nanovector ASA: Allocation of PSUs
- Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL
- Nordic Nanovector ASA - Financial Calendar
- Nordic Nanovector ASA - Results for the Third Quarter 2019
- Nordic Nanovector to Participate in Four Upcoming Investor Conferences
- Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
- Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider
- Nordic Nanovector ASA - Resolution not to Proceed With a Repair Offering
Nordic Nanovector ASA (NANO:OSL) closed at 27.20, 37.72% above the 52 week low of 19.75 set on Oct 24, 2019.
19.75Oct 24 201953.34Jan 22 2019
Markit short selling activity
|Market cap||1.55bn NOK|
|EPS (TTM)||-7.23 |
Data delayed at least 15 minutes, as of Jan 20 2020 15:11 GMT.